
AstraZeneca to buy U.S. biotech CinCor for as much as $1.8 billion By Investing.com
© Reuters. By Scott Kanowsky Investing.com — AstraZeneca PLC (LON:) has agreed to acquire U.S. biotech CinCor Pharma Inc (NASDAQ:) in a deal worth as much as $1.8 billion, as the Anglo-Swedish drugmaker looks to […]